The management of inhibitors in haemophilia A: introduction and systematic review of current practice
- 26 June 2003
- journal article
- review article
- Published by Wiley in Haemophilia
- Vol. 9 (4) , 405-417
- https://doi.org/10.1046/j.1365-2516.2003.00779.x
Abstract
Summary. Haemophilia is the commonest bleeding disorder in the UK, affecting approximately 5400 people, almost all of them male. In haemophiliacs, reduced levels, or absence, of factor VIII (FVIII) ...Keywords
This publication has 28 references indexed in Scilit:
- THE DIAGNOSIS and MANAGEMENT OF FACTOR VIII and IX INHIBITORS: A GUIDELINE FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANIZATION (UKHCDO)British Journal of Haematology, 2000
- Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in ItalyHaemophilia, 2000
- German recommendations for immune tolerance therapy in type A haemophiliacs with antibodiesHaemophilia, 1999
- Analysis of the North American Immune Tolerance Registry (NAITR) 1993–1997: Current Practice ImplicationsVox Sanguinis, 1999
- Tolerance induction using the Malmö treatment model 1982–1995Haemophilia, 1999
- Immunoadsorption for removal of inhibitors: update on treatments in Malmö–Lund between 1980 and 1995Haemophilia, 1998
- Recommendations for the treatment of factor VIII inhibitorsBlood Coagulation & Fibrinolysis, 1996
- The International Registry of Immune Tolerance: 1994 UpdateVox Sanguinis, 1996
- Immune Tolerance for the Treatment of Factor VIII Inhibitors ‐ Twenty Years' ‘Bonn Protocol’Vox Sanguinis, 1996
- Induction of Immune Tolerance in Patients with Hemophilia and Antibodies to Factor VIII by Combined Treatment with Intravenous IgG, Cyclophosphamide, and Factor VIIINew England Journal of Medicine, 1988